EUVIMEDEUVIMED entdecken
Crossref

Natural Products and Chronic Hepatitis B: Unveiling New Therapeutic Horizons

Atul, Rajesh Kumar Verma, Radhika Chaudhary, Sana Fatima, Prashant Sharma, Dharmendra Prasad Singh

RGUHS Journal of AYUSH Sciences · 30.06.2026 · 13 (1) · 24-35

DOI: 10.26463/rjas.13_1_05 ↗

Kurz gefasst

Fachartikel in der Zeitschrift RGUHS Journal of AYUSH Sciences, online erschienen am 30.06.2026. Verfasst von Atul und 5 weiteren Autor:innen. Die Arbeit nennt 56 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The Hepatitis B Virus (HBV) causes inflammation and enlargement of the liver. It can occur in either an acute or chronic form, with Chronic Hepatitis B (CHB) infection presenting significant health challenges worldwide. The two main treatments available for chronic hepatitis at present are Nucleos(t)ide Analogues (NAs) and Interferons (INFs). These options have their limitations, and the possibility of achieving a complete cure is still uncertain. Additionally, there are concerns about vaccine escape and drug resistance mutations in the treatment of HBV. For several decades, Natural Products (NPs) have been a resource for healthcare professionals in the management of chronic hepatitis infections. Compounds derived from various herbs, fungi, and plants have demonstrated antiviral effects. Identifying new NPs is crucial for treating HBV. Various NPs have been documented for their effectiveness against CHB, including alkaloids, artemisinin, ellagic acid, iminosugars, and epigallocatechin gallate. Additionally, other types of NPs, such as marine compounds, microbial fermentation products, and Plant Polysaccharides (PP), also demonstrate anti-HBV activity. This review focuses on the HBV genome, genotypes, mutations associated with vaccine escape and drug resistance, and the potential of NPs as effective therapeutic agents.

Zitieren

APA

Atul, Verma, R. K., Chaudhary, R., Fatima, S., Sharma, P., & Singh, D. P. (2026). Natural Products and Chronic Hepatitis B: Unveiling New Therapeutic Horizons. RGUHS Journal of AYUSH Sciences, 13(1), 24-35. https://doi.org/10.26463/rjas.13_1_05

Vancouver

Atul, Verma RK, Chaudhary R, Fatima S, Sharma P, Singh DP. Natural Products and Chronic Hepatitis B: Unveiling New Therapeutic Horizons. RGUHS Journal of AYUSH Sciences. 2026;13(1):24-35. doi:10.26463/rjas.13_1_05

BibTeX
@article{Atul2026,
  author = {Atul and Verma, Rajesh Kumar and Chaudhary, Radhika and Fatima, Sana and Sharma, Prashant and Singh, Dharmendra Prasad},
  title = {Natural Products and Chronic Hepatitis B: Unveiling New Therapeutic Horizons},
  journal = {RGUHS Journal of AYUSH Sciences},
  year = {2026},
  volume = {13},
  number = {1},
  pages = {24--35},
  doi = {10.26463/rjas.13_1_05}
}
Kostenlos starten →